SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025318
Filing Date
2021-05-07
Accepted
2021-05-07 08:01:57
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-10q_20210331.htm   iXBRL 10-Q 1655840
2 EX-10.1 vrca-ex101_8.htm EX-10.1 830622
3 EX-31.1 vrca-ex311_6.htm EX-31.1 17016
4 EX-31.2 vrca-ex312_7.htm EX-31.2 16955
5 EX-32.1 vrca-ex321_9.htm EX-32.1 11191
6 GRAPHIC gkg2ymzgrn0f000002.jpg GRAPHIC 28241
7 GRAPHIC gkg2ymzgrn0f000001.jpg GRAPHIC 4314
  Complete submission text file 0001564590-21-025318.txt   7460714

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA vrca-20210331.xsd EX-101.SCH 42280
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20210331_cal.xml EX-101.CAL 49449
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20210331_def.xml EX-101.DEF 147462
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20210331_lab.xml EX-101.LAB 376782
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20210331_pre.xml EX-101.PRE 270715
13 EXTRACTED XBRL INSTANCE DOCUMENT vrca-10q_20210331_htm.xml XML 1200600
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 21900330
SIC: 2834 Pharmaceutical Preparations